Alembic Pharma Formulation Scientist Interview: Rounds, Questions and Preparation

What the job involves

A Formulation Scientist in the pharma sector develops and optimises drug formulations, from pre-formulation studies to final dosage forms like tablets, capsules, or injectables. The role involves designing experiments, analysing stability data, and ensuring products meet regulatory and quality standards for manufacturing. Freshers typically support senior scientists in lab work, documentation, and scale-up activities.

Role and Technical Knowledge

1. 1

   What are the key differences between pre-formulation and formulation development?

   Explain that pre-formulation studies characterise the drug's physicochemical properties, while formulation development uses that data to design a stable and bioavailable dosage form.

2. 2

   How would you approach formulating a poorly soluble drug for oral administration?

   Mention techniques like particle size reduction, solid dispersions, cyclodextrin complexation, or lipid-based systems, and relate them to bioavailability enhancement.

3. 3

   What are the critical quality attributes (CQAs) for a tablet formulation?

   List attributes such as hardness, friability, disintegration time, dissolution profile, content uniformity, and stability, and explain why each matters.

4. 4

   Explain the role of excipients in a formulation with examples.

   Cover categories like diluents, binders, disintegrants, lubricants, and glidants, and give specific examples such as microcrystalline cellulose or magnesium stearate.

Practical Scenarios and Problem-Solving

1. 5

   During a dissolution test, the drug release is slower than expected. What steps would you take to investigate?

   Discuss checking formulation factors (e.g., binder concentration, compression force), analytical factors (e.g., media, apparatus), and suggest adjustments like optimising disintegrant level.

2. 6

   How would you handle a stability study where the drug degrades faster than anticipated?

   Outline investigating degradation pathways, evaluating packaging, adding stabilisers, or modifying storage conditions, and emphasise documentation and regulatory impact.

3. 7

   You need to scale up a lab formulation to pilot scale. What challenges might arise?

   Mention changes in mixing, granulation, drying, and compression parameters, and the need for process optimisation and in-process controls.

4. 8

   If an excipient is out of stock, how would you select an alternative without affecting the formulation?

   Focus on understanding the excipient's function, evaluating substitutes with similar properties, and conducting compatibility and stability studies before switching.

Behavioural and HR Questions

1. 9

   Tell me about a time you worked in a team to complete a project under a tight deadline.

   Use the STAR method to describe a specific academic or internship project, highlighting your role, collaboration, and outcome.

2. 10

   Why do you want to work in formulation development, and why our company?

   Show passion for drug development, mention the company's reputation in generics or specialty pharma, and align your career goals with their work.

3. 11

   Describe a situation where you made a mistake in a lab experiment. How did you handle it?

   Be honest, emphasise learning from the error, and explain corrective actions taken and how you prevented recurrence.

4. 12

   How do you prioritise tasks when you have multiple experiments and documentation to complete?

   Discuss time management, using tools like checklists, and communicating with supervisors to align priorities without compromising quality.

Regulatory and Quality Aspects

1. 13

   What is the importance of ICH guidelines in formulation development?

   Explain that ICH provides harmonised standards for stability, analytical validation, and quality, ensuring global regulatory acceptance.

2. 14

   How do GMP and GLP differ in the context of a formulation lab?

   Clarify that GMP governs manufacturing processes and quality systems, while GLP focuses on non-clinical laboratory studies and data integrity.

3. 15

   What documentation is essential when developing a new formulation?

   Mention batch records, protocols, analytical reports, stability data, and change controls, and stress the importance of traceability and accuracy.

4. 16

   Why is bioequivalence important for generic formulations?

   Explain that bioequivalence demonstrates the generic performs similarly to the reference product in terms of rate and extent of absorption, ensuring safety and efficacy.